Search research articles
Contact Us
Filters
Showing results (1-10 of 38) with videos related to
Page
of 4
Sort By:
IARC Scientific Publications
|
January 1, 1986
Mathematical models and natural history in cervical cancer screening
P C Prorok
The American Journal of Pediatric Hematology/Oncology
|
May 1, 1992
Epidemiologic approach for cancer screening. Problems in design and analysis of trials
P C Prorok
Statistics in Medicine
|
March 15, 1994
A data-analytic approach for estimating lead time and screening benefit based on survival curves in randomized cancer screening trials
K Kafadar, P C Prorok
Statistics in Medicine
|
December 30, 1995
Non-parametric estimation of the post-lead-time survival distribution of screen-detected cancer cases
J L Xu, P C Prorok
Controlled Clinical Trials
|
April 1, 1994
Issues in the mortality analysis of randomized controlled trials of cancer screening
R J Connor, P C Prorok
International Journal of Epidemiology
|
March 1, 1986
An analysis of the mortality effect in a breast cancer screening study
J L Aron, P C Prorok
Biometrics
|
September 29, 1998
Estimating a distribution function of the tumor size at metastasis
J L Xu, P C Prorok
Cancer Investigation
|
January 1, 1986
Screening for the early detection of cancer
P C Prorok, R J Connor
American Journal of Epidemiology
|
November 1, 1983
Lead time estimation in a controlled screening program
J S Chen, P C Prorok
Biometrics
|
June 1, 1997
Nonparametric estimation of solid cancer size at metastasis and probability of presenting with metastasis at detection
J L Xu, P C Prorok
Page
of 4
Search research articles
Search
Showing results (1-10 of 38) with videos related to
Sort By:
Page
of 4
IARC Scientific Publications
|
January 1, 1986
Mathematical models and natural history in cervical cancer screening
P C Prorok
The American Journal of Pediatric Hematology/Oncology
|
May 1, 1992
Epidemiologic approach for cancer screening. Problems in design and analysis of trials
P C Prorok
Statistics in Medicine
|
March 15, 1994
A data-analytic approach for estimating lead time and screening benefit based on survival curves in randomized cancer screening trials
K Kafadar, P C Prorok
Statistics in Medicine
|
December 30, 1995
Non-parametric estimation of the post-lead-time survival distribution of screen-detected cancer cases
J L Xu, P C Prorok
Controlled Clinical Trials
|
April 1, 1994
Issues in the mortality analysis of randomized controlled trials of cancer screening
R J Connor, P C Prorok
International Journal of Epidemiology
|
March 1, 1986
An analysis of the mortality effect in a breast cancer screening study
J L Aron, P C Prorok
Biometrics
|
September 29, 1998
Estimating a distribution function of the tumor size at metastasis
J L Xu, P C Prorok
Cancer Investigation
|
January 1, 1986
Screening for the early detection of cancer
P C Prorok, R J Connor
American Journal of Epidemiology
|
November 1, 1983
Lead time estimation in a controlled screening program
J S Chen, P C Prorok
Biometrics
|
June 1, 1997
Nonparametric estimation of solid cancer size at metastasis and probability of presenting with metastasis at detection
J L Xu, P C Prorok
Page
of 4